Financial Ratios APT Medical Inc.

Stocks

688617

CNE100004C45

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 17/06/2026			5-day change	1st Jan Change
196.40 ^CNY	+0.26%		+1.02%	-19.27%

05-21	Tranche Update on APT Medical Inc.'s Equity Buyback Plan announced on May 11, 2026.	CI
05-20	APT Medical Inc.'s Equity Buyback announced on May 11, 2026, has closed with 432,436 shares, representing 0.31% for CNY 99.98 million.	CI

862e.40cyyU81Wy81yVCglQ6o6hHuQwl0dBvp90u0jPnoLSE.oRJTljlxFGoF_hb6-UuakH-cdj4XBXeD2hHC-Z3cX0WxJkqAfWNtYV6MNw

Published financial data: APT MEDICAL INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	823M	1.2B	1.64B	2.05B	2.57B
Other Revenues, Total	5.82M	11.55M	8.49M	16.62M	16.41M
Total Revenues	829M	1.22B	1.65B	2.07B	2.58B
Cost of Goods Sold, Total	259M	354M	486M	580M	707M
Gross Profit	570M	862M	1.16B	1.49B	1.88B
Selling General & Admin Expenses, Total	250M	308M	387M	464M	579M
Provision for Bad Debts	-511K	790K	-178K	2.22M	16.29M
R&D Expenses	135M	175M	238M	291M	365M
Other Operating Expenses	8.14M	13.75M	14.52M	15.22M	28.18M
Other Operating Expenses, Total	393M	497M	639M	772M	989M
Operating Income	177M	365M	525M	714M	888M
Interest Expense, Total	-1.63M	-1.45M	-3.69M	-2.01M	-1.46M
Interest And Investment Income	13.26M	23.94M	27.74M	25.23M	30.73M
Net Interest Expenses	11.64M	22.49M	24.05M	23.23M	29.27M
Currency Exchange Gains (Loss)	-1M	1.17M	2.66M	2.83M	-5.3M
Other Non Operating Income (Expenses)	-499K	-490K	-35.61K	-817K	-829K
EBT, Excl. Unusual Items	187M	388M	552M	739M	911M
Impairment of Goodwill	-	-	-3.84M	-	-
Gain (Loss) On Sale Of Investments	21.72M	342K	-	-16.7M	486K
Gain (Loss) On Sale Of Assets	-51.8K	56.21K	11.97M	253K	-927K
Asset Writedown	-3.5M	-10.68M	-123K	-833K	-1.85M
Other Unusual Items	16.58M	17.25M	36.83M	24.42M	27.43M
EBT, Incl. Unusual Items	222M	395M	596M	746M	936M
Income Tax Expense	26.7M	54.98M	74.24M	87.8M	129M
Earnings From Continuing Operations	195M	340M	522M	658M	808M
Net Income to Company	195M	340M	522M	658M	808M
Minority Interest	13.07M	17.86M	11.79M	14.98M	12.9M
Net Income - (IS)	208M	358M	534M	673M	821M
Net Income to Common Incl Extra Items	208M	358M	534M	673M	821M
Net Income to Common Excl. Extra Items	208M	358M	534M	673M	821M
Per Share Items
Net EPS - Basic	1.52	2.56	3.82	4.8	5.82
Basic EPS - Continuing Operations	1.52	2.56	3.82	4.8	5.82
Basic Weighted Average Shares Outstanding	137M	140M	140M	140M	141M
Net EPS - Diluted	1.51	2.52	3.77	4.77	5.8
Diluted EPS - Continuing Operations	1.51	2.52	3.77	4.77	5.8
Diluted Weighted Average Shares Outstanding	138M	142M	142M	141M	141M
Normalized Basic EPS	0.95	1.86	2.55	3.4	4.13
Normalized Diluted EPS	0.94	1.83	2.52	3.38	4.12
Dividend Per Share	0.48	0.78	0.95	1.21	1
Payout Ratio	15.97	19.28	21.02	19.9	20.75
Supplemental Items
EBITDA	204M	405M	580M	790M	988M
EBITA	177M	367M	528M	719M	893M
EBIT	177M	365M	525M	714M	888M
EBITDAR	205M	406M	581M	796M	998M
Total Revenues (As Reported)	829M	1.22B	1.65B	2.07B	2.58B
Effective Tax Rate - (Ratio)	12.05	13.91	12.45	11.77	13.73
Total Current Taxes	34.9M	55.62M	79.14M	103M	140M
Total Deferred Taxes	-8.2M	-642K	-4.9M	-15.13M	-11.3M
Normalized Net Income	130M	260M	357M	477M	582M
Interest Capitalized	82.6K	-	-	-	-
Interest on Long-Term Debt	522K	436K	693K	539K	533K
Supplemental Operating Expense Items
Marketing Expenses	33M	41.59M	46.16M	57.73M	90.38M
Selling and Marketing Expenses	195M	241M	305M	373M	461M
General and Administrative Expenses	55.12M	66.55M	82.26M	91.52M	119M
Research And Development Expense From Footnotes	135M	175M	238M	291M	365M
Net Rental Expense, Total	741K	726K	933K	5.63M	9.69M
Imputed Operating Lease Interest Expense	237K	170K	387K	1.79M	7.38M
Imputed Operating Lease Depreciation	505K	556K	547K	3.84M	2.31M
Stock-Based Comp., R&D Exp. (Total)	9.17M	11.43M	8.96M	3.34M	2.09M
Stock-Based Comp., S&M Exp. (Total)	4.06M	4.09M	3.46M	1.57M	1.07M
Stock-Based Comp., G&A Exp. (Total)	3.96M	4.63M	5.07M	1.92M	1.48M
Stock-Based Comp., Other (Total)	971K	1.6M	829K	408K	132K
Total Stock-Based Compensation	18.17M	21.75M	18.32M	7.24M	4.77M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	310M	251M	1.28B	1.08B	1.26B
Trading Asset Securities, Total	914M	881M	60M	-	250M
Total Cash And Short Term Investments	1.22B	1.13B	1.34B	1.08B	1.51B
Accounts Receivable, Total	34.01M	47.15M	41.78M	83.29M	78.22M
Other Receivables	13.45M	14.14M	8.76M	20.45M	14.81M
Total Receivables	47.46M	61.29M	50.54M	104M	93.03M
Inventory	263M	338M	328M	399M	492M
Other Current Assets, Total	19.15M	26.01M	41.18M	32.54M	22.35M
Total Current Assets	1.55B	1.56B	1.76B	1.62B	2.12B
Gross Property Plant And Equipment	363M	466M	668M	940M	1.17B
Accumulated Depreciation	-105M	-147M	-204M	-268M	-341M
Net Property Plant And Equipment	259M	320M	464M	672M	833M
Long-term Investments	121M	178M	160M	179M	163M
Goodwill	-	-	48.13M	48.13M	48.13M
Other Intangibles, Total	32.38M	38.92M	83M	402M	390M
Deferred Tax Assets Long-Term	9.82M	12.64M	10.73M	27.44M	39.79M
Deferred Charges Long-Term	7.41M	5.09M	5.95M	3.4M	2.7M
Other Long-Term Assets, Total	30.24M	114M	44.83M	32.55M	53.17M
Total Assets	2.01B	2.23B	2.57B	2.98B	3.65B
Liabilities
Accounts Payable, Total	18M	34.65M	29.56M	46.32M	60.32M
Accrued Expenses, Total	94.76M	119M	161M	192M	239M
Short-term Borrowings	16M	30M	70M	-	-
Current Portion of Long-Term Debt	6.09M	7.27M	1.18M	591K	160K
Current Portion of Leases	7.46M	6.26M	10.1M	5.83M	7.67M
Current Income Taxes Payable	9.35M	13.3M	19.86M	27.1M	40.83M
Unearned Revenue Current, Total	32.32M	38.65M	44.4M	45.66M	54.34M
Other Current Liabilities	10.55M	163M	252M	88.39M	56.15M
Total Current Liabilities	195M	412M	588M	406M	459M
Long-Term Debt	10.23M	1.77M	591K	-	3.76M
Long-Term Leases	6.8M	7.29M	7.99M	4.87M	7.81M
Unearned Revenue Non Current	7.3M	7.06M	8.74M	11.26M	47.55M
Deferred Tax Liability Non Current	3.16M	6.92M	5.49M	2.74M	2.41M
Other Non Current Liabilities	-	-	-	1.02M	1.02M
Total Liabilities	222M	435M	611M	426M	522M
Common Stock, Total	66.67M	66.67M	66.86M	97.39M	141M
Additional Paid In Capital	1.27B	1.01B	724M	785M	703M
Retained Earnings	425M	717M	1.14B	1.68B	2.34B
Treasury Stock	-	-59.99M	-59.99M	-59.99M	-99.94M
Comprehensive Income and Other	17.89M	27.22M	34.96M	9.6M	1.35M
Total Common Equity	1.78B	1.76B	1.91B	2.52B	3.09B
Minority Interest	12.95M	27.75M	54.86M	38.5M	41.68M
Total Equity	1.79B	1.79B	1.96B	2.55B	3.13B
Total Liabilities And Equity	2.01B	2.23B	2.57B	2.98B	3.65B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	140M	140M	140M	141M	141M
ECS Total Common Shares Outstanding	140M	140M	140M	141M	141M
Book Value / Share	12.69	12.64	13.63	17.9	21.96
Tangible Book Value	1.75B	1.72B	1.78B	2.07B	2.65B
Tangible Book Value Per Share	12.45	12.36	12.69	14.7	18.85
Total Debt	46.58M	52.59M	89.86M	11.29M	19.4M
Net Debt	-1.18B	-1.08B	-1.25B	-1.07B	-1.5B
Debt Equivalent Oper. Leases	5.93M	5.81M	7.47M	45.04M	77.52M
Minority Interest, Total (Incl. Fin. Div)	12.95M	27.75M	54.86M	38.5M	41.68M
Equity Method Investments, Total	57.27M	84.83M	38.66M	101M	112M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	174M	218M	201M	221M	277M
Inventories - Work In Process, Total	32.18M	47.84M	56M	70.87M	82.84M
Inventories - Finished Goods, Total	61.22M	71.58M	82.72M	121M	149M
Inventories - Others	2.43M	4.99M	3.29M	4.39M	1.49M
Buildings, Total	81.94M	150M	173M	262M	290M
Machinery, Total	224M	277M	403M	591M	710M
Full Time Employees	1.51K	1.74K	2.16K	2.56K	3.12K
Accumulated Allowance for Doubtful Accounts (Supple)	2.64M	3.45M	3.28M	5.44M	21.39M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	208M	358M	534M	673M	821M
Depreciation & Amortization - CF	32.43M	45.96M	60.38M	81.06M	105M
Amortization of Goodwill and Intangible Assets - (CF)	750K	1.56M	3.63M	5.65M	5.07M
Depreciation & Amortization, Total	33.18M	47.52M	64.01M	86.71M	110M
Amortization of Deferred Charges, Total - (CF)	1.37M	3.96M	3.88M	4.33M	3.07M
(Gain) Loss From Sale Of Asset	-16.58K	-56.21K	-10.81M	-253K	927K
(Gain) Loss on Sale of Investments - (CF)	-32.82M	-21.09M	-23.13M	3.53M	-17.42M
Asset Writedown & Restructuring Costs	9.81M	10.68M	3.97M	833K	1.86M
Provision for Credit Losses	-	-	-	-	-
Provision and Write-off of Bad Debts	-511K	790K	-178K	2.22M	16.29M
Other Operating Activities, Total	-10.11M	-13.45M	906K	303K	706K
Change In Accounts Receivable	4.3M	-23.17M	20M	-74.73M	-121M
Change In Inventories	-124M	-72.59M	11.22M	-79.29M	-111M
Change In Accounts Payable	82.51M	61.71M	68.9M	134M	270M
Change In Deferred Taxes	-8.2M	939K	-4.9M	-15.13M	-11.3M
Change in Other Net Operating Assets	18.17M	14.19M	21.28M	7.24M	5.69M
Cash from Operations	181M	367M	689M	743M	968M
Capital Expenditure	-167M	-143M	-202M	-650M	-286M
Sale of Property, Plant, and Equipment	36.03K	229K	12.67M	604K	223K
Cash Acquisitions	-	-	-46.37M	-	-
Investment in Marketable and Equity Securities, Total	-948M	-39.16M	798M	23.84M	-223M
Other Investing Activities, Total	4.93M	47.61M	19.82M	8.01M	-10.75M
Cash from Investing	-1.11B	-135M	582M	-618M	-519M
Short Term Debt Issued, Total	-	-	-	12.5M	15M
Long-Term Debt Issued, Total	48.5M	82.6M	70M	-	4M
Total Debt Issued	48.5M	82.6M	70M	12.5M	19M
Short Term Debt Repaid, Total	-	-	-	-5.04M	-373K
Long-Term Debt Repaid, Total	-30.27M	-84.16M	-49.62M	-82.74M	-11.02M
Total Debt Repaid	-30.27M	-84.16M	-49.62M	-87.78M	-11.39M
Issuance of Common Stock	1.2B	19M	34.67M	78.53M	35.94M
Repurchase of Common Stock	-	-59.99M	-	-	-99.94M
Common Dividends Paid	-33.19M	-69.01M	-112M	-134M	-170M
Common & Preferred Stock Dividends Paid	-33.19M	-69.01M	-112M	-134M	-170M
Other Financing Activities, Total	-64.99M	-183M	-189M	-177M	-53.07M
Cash from Financing	1.12B	-295M	-246M	-308M	-280M
Foreign Exchange Rate Adjustments	-1.02M	958K	2.84M	-13M	-3.79M
Net Change in Cash	189M	-60.71M	1.03B	-195M	165M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	78.34M	146M	204M	251M	331M
Levered Free Cash Flow	-34.12M	265M	354M	-330M	366M
Unlevered Free Cash Flow	-33.1M	266M	356M	-329M	367M
Change In Net Working Capital	28.87M	-108M	-144M	223M	20.15M
Net Debt Issued / Repaid	18.23M	-1.56M	20.38M	-75.28M	7.61M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.49	10.76	13.67	16.06	16.74
Return on Total Capital	9.49	12.39	16.84	19.32	19.42
Return On Equity %	17.39	18.99	27.82	29.14	28.42
Return on Common Equity	18.58	20.22	29.09	30.44	29.28
Margin Analysis
Gross Profit Margin %	68.74	70.89	70.54	71.93	72.62
SG&A Margin	30.22	25.29	23.45	22.48	22.42
EBITDA Margin %	24.65	33.3	35.15	38.25	38.26
EBITA Margin %	21.41	30.14	32.03	34.82	34.56
EBIT Margin %	21.32	30.02	31.81	34.54	34.37
Income From Continuing Operations Margin %	23.51	27.97	31.64	31.86	31.26
Net Income Margin %	25.09	29.44	32.35	32.59	31.76
Net Avail. For Common Margin %	25.09	29.44	32.35	32.59	31.76
Normalized Net Income Margin	15.67	21.42	21.6	23.08	22.54
Levered Free Cash Flow Margin	-4.12	21.81	21.45	-16	14.16
Unlevered Free Cash Flow Margin	-3.99	21.89	21.59	-15.94	14.2
Asset Turnover
Asset Turnover	0.64	0.57	0.69	0.74	0.78
Fixed Assets Turnover	4	4.2	4.21	3.64	3.44
Receivables Turnover (Average Receivables)	21.17	29.68	36.92	32.77	31.79
Inventory Turnover (Average Inventory)	1.27	1.18	1.46	1.59	1.59
Short Term Liquidity
Current Ratio	7.98	3.78	2.99	3.98	4.62
Quick Ratio	6.53	2.9	2.36	2.92	3.5
Operating Cash Flow to Current Liabilities	0.93	0.89	1.17	1.83	2.11
Days Sales Outstanding (Average Receivables)	17.24	12.3	9.89	11.17	11.48
Days Outstanding Inventory (Average Inventory)	287.77	309.9	249.98	229.51	229.94
Average Days Payable Outstanding	12.68	22.41	24.61	25.02	24.32
Cash Conversion Cycle (Average Days)	292.33	299.78	235.25	215.66	217.1
Long Term Solvency
Total Debt/Equity	2.6	2.94	4.58	0.44	0.62
Total Debt / Total Capital	2.53	2.85	4.38	0.44	0.62
LT Debt/Equity	0.95	0.51	0.44	0.19	0.37
Long-Term Debt / Total Capital	0.93	0.49	0.42	0.19	0.37
Total Liabilities / Total Assets	11.03	19.54	23.75	14.29	14.28
EBIT / Interest Expense	108.65	251.42	142.29	355.86	608.06
EBITDA / Interest Expense	129.06	284.15	159.64	399.11	683.22
(EBITDA - Capex) / Interest Expense	26.13	185.51	104.87	74.83	487.66
Total Debt / EBITDA	0.22	0.13	0.15	0.01	0.02
Net Debt / EBITDA	-5.61	-2.62	-2.12	-1.34	-1.5
Total Debt / (EBITDA - Capex)	1.1	0.2	0.23	0.08	0.03
Net Debt / (EBITDA - Capex)	-27.7	-4.01	-3.22	-7.13	-2.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	72.85	46.74	35.71	25.18	25.08
Gross Profit, 1 Yr. Growth %	68.87	51.33	35.05	27.65	26.29
EBITDA, 1 Yr. Growth %	61.47	99	42.99	36.04	24.97
EBITA, 1 Yr. Growth %	62.8	107.46	43.89	35.88	24.04
EBIT, 1 Yr. Growth %	65.93	107.76	43.8	35.96	24.44
Earnings From Cont. Operations, 1 Yr. Growth %	87.01	74.57	53.5	26.05	22.73
Net Income, 1 Yr. Growth %	87.7	72.19	49.13	26.08	21.91
Normalized Net Income, 1 Yr. Growth %	78.12	101.59	36.87	33.73	22.15
Diluted EPS Before Extra, 1 Yr. Growth %	42.79	67.2	49.43	26.74	21.85
Accounts Receivable, 1 Yr. Growth %	-22.2	38.62	-11.39	99.37	-6.09
Inventory, 1 Yr. Growth %	81.21	28.37	-2.96	21.76	23.2
Net Property, Plant and Equip., 1 Yr. Growth %	66.81	23.65	45.18	44.59	24
Total Assets, 1 Yr. Growth %	241.95	10.58	15.59	15.85	22.52
Tangible Book Value, 1 Yr. Growth %	307.99	-1.22	2.99	16.34	28.26
Common Equity, 1 Yr. Growth %	286.25	-0.83	8.16	31.94	22.74
Cash From Operations, 1 Yr. Growth %	22.36	102.58	87.52	7.88	30.18
Capital Expenditures, 1 Yr. Growth %	278.68	-14.44	41.08	221.86	-56.08
Levered Free Cash Flow, 1 Yr. Growth %	-185.88	-842.59	34.29	-193.57	-210.59
Unlevered Free Cash Flow, 1 Yr. Growth %	-182.24	-866.96	34.7	-192.61	-211.29
Dividend Per Share, 1 Yr. Growth %	100	65.01	21.2	26.88	-17.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	43.23	59.26	41.12	30.34	25.13
Gross Profit, 2 Yr. CAGR %	41.17	59.86	42.96	31.3	26.97
EBITDA, 2 Yr. CAGR %	41.01	78.93	68.84	39.57	30.45
EBITA, 2 Yr. CAGR %	40.6	83.39	72.95	39.94	29.89
EBIT, 2 Yr. CAGR %	41.67	85.14	72.85	39.83	30.07
Earnings From Cont. Operations, 2 Yr. CAGR %	57.98	80.68	63.7	39.1	24.38
Net Income, 2 Yr. CAGR %	58.68	79.78	60.25	37.12	23.98
Normalized Net Income, 2 Yr. CAGR %	47.83	89.03	66.11	35.29	27.81
Diluted EPS Before Extra, 2 Yr. CAGR %	38.6	54.51	58.06	37.59	24.11
Accounts Receivable, 2 Yr. CAGR %	-14.99	3.85	10.83	32.91	36.83
Inventory, 2 Yr. CAGR %	35.76	52.52	11.62	8.7	22.48
Net Property, Plant and Equip., 2 Yr. CAGR %	39.25	43.62	33.98	44.88	33.9
Total Assets, 2 Yr. CAGR %	89.43	94.45	13.05	15.72	19.13
Tangible Book Value, 2 Yr. CAGR %	166.49	100.75	0.86	9.46	22.16
Common Equity, 2 Yr. CAGR %	125.53	95.71	3.56	19.46	27.26
Cash From Operations, 2 Yr. CAGR %	81.77	57.44	94.9	42.23	18.51
Capital Expenditures, 2 Yr. CAGR %	57.39	80	9.86	113.09	18.9
Levered Free Cash Flow, 2 Yr. CAGR %	-16.99	158.38	214.83	11.97	1.79
Unlevered Free Cash Flow, 2 Yr. CAGR %	-18.1	157.14	220.45	11.56	1.59
Dividend Per Share, 2 Yr. CAGR %	-	81.67	41.42	24.01	2.53
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	50.77	44.39	50.99	35.59	28.56
Gross Profit, 3 Yr. CAGR %	50.74	44.48	51.12	37.66	29.6
EBITDA, 3 Yr. CAGR %	98.22	57.98	66.14	57.18	34.56
EBITA, 3 Yr. CAGR %	117.6	59.84	69.26	59.67	34.47
EBIT, 3 Yr. CAGR %	117.8	60.65	70.18	59.56	34.5
Earnings From Cont. Operations, 3 Yr. CAGR %	126.92	63.33	71.12	50.04	33.41
Net Income, 3 Yr. CAGR %	113.01	63.06	68.92	47.94	31.85
Normalized Net Income, 3 Yr. CAGR %	100.76	63.67	69.75	54.53	30.76
Diluted EPS Before Extra, 3 Yr. CAGR %	94.63	47.55	52.8	46.83	32.02
Accounts Receivable, 3 Yr. CAGR %	10.21	0.06	-1.5	34.79	18.38
Inventory, 3 Yr. CAGR %	48.51	33.25	31.18	14.9	13.33
Net Property, Plant and Equip., 3 Yr. CAGR %	36.96	33.85	44.14	37.43	37.56
Total Assets, 3 Yr. CAGR %	83.5	58.31	63.5	13.98	17.94
Tangible Book Value, 3 Yr. CAGR %	86.57	91.43	60.71	5.78	15.4
Common Equity, 3 Yr. CAGR %	87.48	71.5	60.61	12.27	20.54
Cash From Operations, 3 Yr. CAGR %	113.53	88.46	66.89	60.03	38.1
Capital Expenditures, 3 Yr. CAGR %	73.23	28.45	65.96	57.2	25.87
Levered Free Cash Flow, 3 Yr. CAGR %	31.9	74.98	107.32	109.94	11.55
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.07	75.37	106.87	111.7	11.52
Dividend Per Share, 3 Yr. CAGR %	-	-	58.74	36.4	8.41
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	51.34	46.83	38.6	40.06
Gross Profit, 5 Yr. CAGR %	-	52.24	47.58	39.05	40.95
EBITDA, 5 Yr. CAGR %	-	83.4	85.76	50.39	50.86
EBITA, 5 Yr. CAGR %	-	97.83	98.33	51.62	52.3
EBIT, 5 Yr. CAGR %	-	98	98.34	51.97	52.84
Earnings From Cont. Operations, 5 Yr. CAGR %	-	65.88	99.13	53.17	50.62
Net Income, 5 Yr. CAGR %	-	59.68	90.09	52.14	49.26
Normalized Net Income, 5 Yr. CAGR %	-	58.29	85.93	51.67	51.53
Diluted EPS Before Extra, 5 Yr. CAGR %	-	50.36	79.08	43.48	40.59
Accounts Receivable, 5 Yr. CAGR %	-	9.47	10.46	12.1	12.34
Inventory, 5 Yr. CAGR %	-	50.46	32.48	22.83	27.63
Net Property, Plant and Equip., 5 Yr. CAGR %	-	35.78	35.76	38.16	39.95
Total Assets, 5 Yr. CAGR %	-	54.51	51.18	39.66	44.05
Tangible Book Value, 5 Yr. CAGR %	-	51.93	45.88	53.08	44.01
Common Equity, 5 Yr. CAGR %	-	52.44	47.86	48.4	46.33
Cash From Operations, 5 Yr. CAGR %	-	95.36	105.87	68.4	45.53
Capital Expenditures, 5 Yr. CAGR %	-	41.48	44.39	57.28	45.23
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	88.52	46.18	55.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	89.19	46.17	55.58
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	33.28